Compare Strategy Inc. (MSTR) vs Recursion Pharmaceuticals Inc (RXRX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Strategy Inc. vs Recursion Pharmaceuticals Inc — how do they compare? Strategy Inc. trades at $101.67 (market cap $35.47B), while Recursion Pharmaceuticals Inc trades at $3.08 (market cap $1.53B). The key difference: Strategy Inc. is far larger — about 23.2× Recursion Pharmaceuticals Inc's market cap. Which is the better fit depends on your goals.
| MSTR | RXRX | |
|---|---|---|
Market Cap | $35.47B | $1.53B |
Sector | Technology | Health |
52-Week High | $426.40 | $6.79 |
52-Week Low | $82.31 | $2.84 |
Enterprise Value | $50.50B | $946.50M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Strategy Inc.
MicroStrategy Inc is a provider of enterprise analytics and mobility software. It offers MicroStrategy Analytics platform that delivers reports and dashboards and enables users to conduct ad hoc analysis and share insights through mobile devices or the Web
Read more on MSTR →About Recursion Pharmaceuticals Inc
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company leveraging artificial intelligence (AI) and machine learning to industrialize drug discovery. The company's unique approach combines one of the world's largest biological and chemical datasets with automated wet-lab and computational systems to map human biology and identify potential therapeutic candidates across a range of diseases, including oncology and rare diseases. Recursion aims to accelerate the traditionally slow and expensive process of drug development.
Read more on RXRX →
